The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.

Monday, 1st June 2009 (5314 views)

An Australian nanotechnology company has made progress in the development of a new drug delivery technique.

NanoVentures Australia (NVA) has developed a new mechanism that could potentially be used in the manufacturing of low-cost inhaler devices, Azo Nanotechnology reports.

The firm's predecessor Nanotechnology Victoria had invested extensively in the development of new surface acoustic wave (Saw) technology, which allows fluid to be atomised as droplets.

Working in partnership with Monash University's Micro NanoPhysics Research Laboratory, the company utilised nanotechnology - which often involves gold use - to make the breakthrough.

It is hoped that the Saw technology will lead to the development of an inhaler that can deliver drugs like insulin, after previous attempts to develop such a device were found to be unsuccessful.

Chemistry professor at Portland State University in the US Mingdi Yan recently claimed that nanotechnology can play a key part in the future of medical science, as it could be used to deliver drugs that target specific cells in the human body.

 

« Back to Gold News stories